SEC probes Baxter on infusion pump recalls | On Call

May 7, 2012 by MassDevice staff

The U.S. Securities & Exchange Commission subpoenas health products giant Baxter International for documents on the recall of its Colleague and Syndeo infusion pumps.

MassDevice On Call

MASSDEVICE ON CALL — Baxter (NYSE:BAX) said the U.S. Securities & Exchange Commission wants documents on the recalls of a pair of its infusion pumps, which the FDA forced from U.S. shelves in 2010.

The Chicago-based company said in a regulatory filing that the financial watchdog sent it a subpoena in March 2012 "related to the company’s accounting treatment, financial reporting and disclosures relating to the remediation and recall of the company’s Colleague and Syndeo infusion pumps," according to the filing. "The company is fully cooperating with this investigation."

Sign up to get our free newsletters delivered straight to your inbox

In May 2010, the FDA made Baxter yank the Colleague line, accusing it of a "long-standing" failure to correct problems with the pumps, and ordered the company to provide refunds to customers or to replace the pumps at no cost.

Problems with infusion pumps in general prompted the FDA to look at stricter regulation of the devices, which are designed to deliver medications, including insulin for diabetes, at a controlled pace. The agency issued nearly 20 recalls over 5 years and said it received more than 56,000 complaints associated with the use of the pumps, scores of which resulted in serious injuries and 500 deaths.

 Family members of Junior Seau, the retired football player who took his life last week, are considering donating his brain to a research facility studying athletes' brains for signs of traumatic injury. Read more